News
-
-
-
PRESS RELEASE
ASCOMP Introduces Synchredible Version 8.2: Streamlined Data Synchronization and Backup for Windows Users
ASCOMP announces the release of Synchredible Version 8.2, offering an easy and efficient way to synchronize, copy, and back up data. The software includes user-friendly features and automation for seamless data management -
-
-
PRESS RELEASE
MindBio Therapeutics Completes World First Take Home Phase 2a Microdosing Depression Trial
MindBio Therapeutics Corp. completes landmark Phase 2a clinical trial in Major Depressive Disorder patients with regulatory approvals for take-home use of proprietary microdose LSD MB22001. Phase 2B trial in late-stage cancer patients ongoing. CEO Justin Hanka announces pivotal moment for psychiatric medicine development -
-
PRESS RELEASE
EQS-Adhoc: Correction of a release from 14/02/2024, 07:51 CET/CEST - AMADEUS FIRE AG: Preliminary figures for the 2023 financial year
Amadeus Fire AG reports record sales and operating EBITA in 2023, with a growth rate of 8.7% and 3.5% respectively. Company overcomes challenges in Personnel Services segment -
-
PRESS RELEASE
Original-Research: Multitude SE (von NuWays AG): BUY
Multitude SE's research update anticipates continued growth as it aims for €30m net income in FY26. With a focus on high-demand loan sectors, controlled risks, and premium loans, the company showcases a promising outlook for investors
